BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to CACO-2 cell line is 123
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DPP4 | 3009 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs and Western Blotting followed by IF staining and SFA | NA | 0.64 | 0.0085 | 31285270 |
| EPCAM | 11529 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs and Western Blotting followed by IF staining and SFA | NA | 0.64 | 0.211 | 31285270 |
| EPCAM | 11529 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | SP assay followed by qPCR and SFA | NA | 0.64 | 0.211 | 32367652 |
| EPCAM | 11529 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | SFA followed by FACs | NA | 0.64 | 0.211 | 26995228 |
| LGR5 | 4504 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs and Western Blotting followed by IF staining and SFA | NA | 0.64 | 0.0753 | 31285270 |
| LGR5 | 4504 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | 5-Fluorouracil | qPCR | NA | 0.64 | 0.0753 | 33946505 |
| LGR5 | 4504 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | SP assay followed by qPCR and SFA | NA | 0.64 | 0.0753 | 32367652 |
| PROM1 | 9454 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | RT-PCR and Western Blotting followed by FACs | NA | 0.6 | 0.7582 | 26002465 |
| PROM1 | 9454 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs followed by Western Blotting | NA | 0.6 | 0.7582 | 22623141 |
| PROM1 | 9454 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | Western Blotting followed by FACs | NA | 0.6 | 0.7582 | 20023382 |
| PROM1 | 9454 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs and CFA followed by SFA and RT-PCR | NA | 0.6 | 0.7582 | 29312609 |
| PROM1 | 9454 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | 5-Fluorouracil | qPCR | NA | 0.6 | 0.7582 | 33946505 |
| PROM1 | 9454 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | RT-PCR | NA | 0.6 | 0.7582 | 28578295 |
| PROM1 | 9454 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | SP assay followed by FACs and SFA | NA | 0.6 | 0.7582 | 32367652 |
| PROM1 | 9454 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs | NA | 0.6 | 0.7582 | 25154976 |
| PROM1 | 9454 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs | NA | 0.6 | 0.7582 | 32729895 |
| PROM1 | 9454 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs and CFA | NA | 0.6 | 0.7582 | 25154976 |
| PROM1 | 9454 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs and Tumorigenicity assay followed by SP assay | NA | 0.6 | 0.7582 | 21826669 |
| PROM1 | 9454 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs followed by SFA | NA | 0.6 | 0.7582 | 31285270 |
| PROM1 | 9454 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | SFA followed by FACs | NA | 0.6 | 0.7582 | 26995228 |
| YAP1 | 16262 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | SFA and CFA followed by FACs and Western Blotting | NA | 0.4 | 0.0117 | 29312609 |
| ANXA2 | 537 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.36 | 0.0032 | 22623141 |
| ANXA2 | 537 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.36 | 0.0032 | 22623141 |
| CSNK2A1 | 2457 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.36 | 0.0011 | 22623141 |
| JUP | 6207 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.36 | 0.0042 | 22623141 |
| ANXA1 | 533 | HTM/LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics and Western Blotting | Up | 0.36 | 0.0053 | 22623141 |
| ANXA1 | 533 | HTM/LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Transcriptomics and qRT-PCR | Down | 0.36 | 0.0053 | 21826669 |
| ANXA2 | 537 | HTM/LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics and Western Blotting | Up | 0.36 | 0.0032 | 22623141 |
| CSNK2A1 | 2457 | HTM/LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics and Western Blotting | Up | 0.36 | 0.0011 | 22623141 |
| CTNNB1 | 2514 | HTM/LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics and Western Blotting | Up | 0.36 | 0.0647 | 22623141 |
| JUP | 6207 | HTM/LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics and Western Blotting | Up | 0.36 | 0.0042 | 22623141 |
| SRSF3 | 10785 | HTM/LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics and Western Blotting | Up | 0.36 | 0.0011 | 22623141 |
| CD44 | 1681 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs followed by IF staining and SFA | NA | 0.36 | 1 | 31285270 |
| CD44 | 1681 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs and CFA followed by SFA and RT-PCR | NA | 0.36 | 1 | 29312609 |
| CD44 | 1681 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | qRT-PCR | NA | 0.36 | 1 | 28565875 |
| CD44 | 1681 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs | NA | 0.36 | 1 | 25154976 |
| CD44 | 1681 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs | NA | 0.36 | 1 | 25154976 |
| ALDH1A1 | 402 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.28 | 0.684 | 22623141 |
| ALDH1A1 | 402 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | Western Blotting | NA | 0.28 | 0.684 | 29235568 |
| ALDH1A1 | 402 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | qRT-PCR | NA | 0.28 | 0.684 | 28565875 |
| ALDH1A1 | 402 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs and CFA | NA | 0.28 | 0.684 | 25154976 |
| ALDH1A1 | 402 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs and CFA | NA | 0.28 | 0.684 | 25154976 |
| ALDH1A1 | 402 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | SFA followed by FACs | NA | 0.28 | 0.684 | 26995228 |
| ALDH1A3 | 409 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | Western Blotting | NA | 0.28 | 0.0201 | 29235568 |
| HMGA1 | 5010 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | Western Blotting | NA | 0.28 | 0.0042 | 24833610 |
| BIK | 1051 | HTM/LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0021 | 21826669 |
| BMP7 | 1074 | HTM/LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0032 | 21826669 |
| CDC42 | 1736 | HTM/LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0042 | 21826669 |
| CXCL2 | 4603 | HTM/LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0074 | 21826669 |
| EDN1 | 3176 | HTM/LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0053 | 21826669 |
| FGF9 | 3687 | HTM/LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0021 | 21826669 |
| GATA2 | 4171 | HTM/LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0021 | 21826669 |
| NR4A2 | 7981 | HTM/LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0042 | 21826669 |
| S100P | 10504 | HTM/LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0106 | 21826669 |
| SMAD7 | 6773 | HTM/LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0032 | 21826669 |
| SOCS2 | 19382 | HTM/LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0053 | 21826669 |
| ALCAM | 400 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | 5-Fluorouracil | qPCR | NA | 0.2 | 0.0583 | 33946505 |
| BMI1 | 1066 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.1135 | 29312609 |
| KLF4 | 6348 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | SP assay followed by qPCR and SFA | NA | 0.2 | 0.0891 | 32367652 |
| KLF5 | 6349 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.0042 | 29312609 |
| MYC | 7553 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.1304 | 29312609 |
| NANOG | 20857 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | SP assay followed by qPCR and SFA | NA | 0.2 | 0.5461 | 32367652 |
| OLFM4 | 17190 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | 5-Fluorouracil | qPCR | NA | 0.2 | 0.0032 | 33946505 |
| POU5F1 | 9221 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.6448 | 29312609 |
| SOX2 | 11195 | LTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | SP assay followed by qPCR and SFA | NA | 0.2 | 0.5695 | 32367652 |
| ACTR3 | 170 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0021 | 22623141 |
| ALDOA | 414 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0042 | 22623141 |
| ANXA6 | 544 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0053 | 22623141 |
| ATP5F1A | 823 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0032 | 22623141 |
| CAT | 1516 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0042 | 22623141 |
| CKB | 1991 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0042 | 22623141 |
| CKB | 1991 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0042 | 22623141 |
| CKB | 1991 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0042 | 22623141 |
| DDX39B | 13917 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0032 | 22623141 |
| DDX3X | 2745 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0011 | 22623141 |
| ECHS1 | 3151 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0042 | 22623141 |
| ESD | 3465 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0011 | 22623141 |
| FARSA | 3592 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0011 | 22623141 |
| FLNA | 3754 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0042 | 22623141 |
| GNPDA1 | 4417 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0011 | 22623141 |
| GPD2 | 4456 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0042 | 22623141 |
| HS3ST3A1 | 5196 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0032 | 22623141 |
| HSP90AB1 | 5258 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0074 | 22623141 |
| HSPA1A | 5232 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0053 | 22623141 |
| HSPA1A | 5232 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0053 | 22623141 |
| HSPA8 | 5241 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0085 | 22623141 |
| HSPA8 | 5241 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0085 | 22623141 |
| HSPD1 | 5261 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0064 | 22623141 |
| IMPDH2 | 6053 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0032 | 22623141 |
| KRT18 | 6430 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0074 | 22623141 |
| KRT8 | 6446 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0074 | 22623141 |
| LACTB2 | 18512 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0032 | 22623141 |
| LDHB | 6541 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0042 | 22623141 |
| LMNA | 6636 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0042 | 22623141 |
| METAP1 | 15789 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0011 | 22623141 |
| MRPS27 | 14512 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0032 | 22623141 |
| NCL | 7667 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0042 | 22623141 |
| PCK2 | 8725 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0042 | 22623141 |
| PCNP | 30023 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0011 | 22623141 |
| PDHA1 | 8806 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0021 | 22623141 |
| PDIA4 | 30167 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0053 | 22623141 |
| PLPBP | 9457 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0032 | 22623141 |
| POLDIP2 | 23781 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0011 | 22623141 |
| PSMC6 | 9553 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0021 | 22623141 |
| SFRS3 | 10785 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0032 | 22623141 |
| SYNCRIP | 16918 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0053 | 22623141 |
| TAPBP | 11566 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0011 | 22623141 |
| TARS1 | 11572 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0011 | 22623141 |
| TCP1 | 11655 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0053 | 22623141 |
| TPT1 | 12022 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0021 | 22623141 |
| TUBA1A | 20766 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0032 | 22623141 |
| TUBB4B | 20771 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0021 | 22623141 |
| TUFM | 12420 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0042 | 22623141 |
| UGDH | 12525 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0053 | 22623141 |
| BDNF | 1033 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0053 | 21826669 |
| CCN2 | 2500 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 21826669 |
| EGR1 | 3238 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0074 | 21826669 |
| FOS | 3796 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0053 | 21826669 |
| JUN | 6204 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0053 | 21826669 |
| JUNB | 6205 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 21826669 |
| MYCN | 7559 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 21826669 |
| NR4A1 | 7980 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 21826669 |
| SERPINA1 | 8941 | HTM | Colon Cancer | Adenocarcinoma | CACO-2 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 21826669 |